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This special issue on Cell Stress and Cell Death is aimed
at bringing together recent developments in the ﬁelds of
cellular stress and cell death and, in particular, the interplay
between cell stress responses and cell death. The special issue
o p e n sw i t har e v i e wb yS .F u l d ae ta l .w h i c hp r o v i d e sa n
overview of how cells can respond to stress in a variety of
ways ranging from the activation of survival pathways to the
initiation of cell death that eventually eliminates damaged
cells. Whether cells mount a protective response or succumb
todeathdependstoalargeextentonthenatureandduration
of the stress as well as the cell type. For example, milder
stresses can lead to protection through activation of the heat
shock response or the unfolded protein response (UPR).
This review also describes several types of cell death (e.g.,
apoptosis, necrosis, pyroptosis, or autophagic cell death) and
the mechanism by which a cell dies often depends on various
exogenous factors as well as the cell’s ability to handle the
stress to which it is exposed. The implications of cellular
stress responses for human physiology and disease are
multifold and are discussed in this review in the context of
some major world health issues such as diabetes, Parkinson’s
disease, myocardial infarction, and cancer.
Therearemanymoleculesandcellularprocessesthatplay
critical roles in normal cell signaling and survival responses,
while also having a dual role in inducing cell death. A
number of papers in this special issue, covering endoplasmic
reticulum (ER) stress and Ca2+, address this topic. In recent
years there has been a signiﬁcant increase in the number
of papers in the ﬁeld dealing with ER stress and ER stress-
induced cell death. This reﬂects the growing recognition of
the importance of the ER in cell stress and in diﬀerent modes
of cell death. The ER is the site of folding of membrane and
secreted proteins in the cell. Physiological or pathological
processes that disturb protein folding in the ER initiate a
complex intracellular signal transduction pathway, known
as the UPR. This response is an attempt to reestablish ER
homeostasis, although it can also lead to cell death. The
review by A. Samali et al. provides a comprehensive overview
of current methodologies for monitoring the UPR and ER
stress, and it puts together a set of criteria to assess this
response, which will be useful for researchers who wish to
examine these phenomena in diﬀerent model systems. The
UPR is essentially tailored to reestablish ER homeostasis and
it can also signal through other adaptive mechanisms involv-
ing the stimulation of autophagy. However, when ER stress
is persistent, the cytoprotective functions of the UPR and
autophagy can switch to cell death-promoting mechanisms.
A review by T. Verfaillie et al. discusses the relationship
between ER stress and autophagy and the implications for
cancer therapy. Recently, a variety of anticancer therapies
have been linked to the induction of ER stress in cancer
cells, envisaging strategies that stimulate prodeath function
or block its prosurvival function, to improve tumoricidial
action. A better understanding of the molecular mechanisms
that determine the ﬁnal outcome of UPR and autophagy
activation by chemotherapeutic agents will oﬀer new oppor-
tunities to improve existing cancer therapies as well as
revealing novel targets for cancer treatment. Prolonged or
severe ER stress has been linked to induction of apoptosis.
Caspase activation is one of the key steps in commitment
of cells to apoptosis and is dependent on mitochondrial
outer membrane permeabilization (MOMP) and the release2 International Journal of Cell Biology
of cytochrome c from the mitochondria. The research article
by S. Gupta et al. investigates the mechanism of ER stress-
induced MOMP using thapsigargin as an inducer of ER
stress.Theygeneticallydissectedtheroleofcaspase-9,-3,and
-2 in the induction of MOMP by ER stress using embryonic
ﬁbroblasts derived from knockout mice and also treated cells
with chemical and molecular inhibitors of the mitochondrial
permeability transition. Their results suggest that caspase-
9 and -2, Bcl-2 family members, and the mitochondrial
permeability transition pore all play a role in MOMP during
ER stress-induced apoptosis.
Ca2+ is an important second messenger which is also
poisedattheintersectionbetweencellsurvivalandcelldeath.
The review by C. Cerella et al. examines the events that occur
during Ca2+ toxicity and how reparative or death pathways
can be activated. They also discuss the observations that
while Ca2+ can elicit these opposing responses, it also plays a
role as a second messenger in signal transduction associated
with cell death and survival.
Knowledge of cell stress and cell death pathways, and the
interplay between these, beneﬁcially provides us with new
ways to tackle diseases, particularly cancers and degenerative
disease. Resistance to apoptosis is a feature of many cancer
cells and this is the subject of the review by S. Fulda
which summarizes the main mechanisms by which cancer
cells evade the intrinsic and extrinsic apoptosis pathways.
Generally, altered ratios of key pro- and antiapoptotic
proteins are responsible for resistance to cell death; for
example, altered ratios of Bcl-2 family proteins as well as
increased expression of caspase inhibitors (IAPs) regulate
the intrinsic pathway, while reduced sensitivity of extrinsic
pathways occurs due to decreased expression of death recep-
tors on the plasma membrane and increased expression of
intracellular decoy proteins. Given this increased resistance
to cell death pathways, the search for novel molecules to
inducecelldeathincancercellsisanimportantgoal.Histone
deacetylase inhibitors have become a promising new avenue
for cancer therapy, and many are currently in clinical trials
for various tumor types. The research article by N. Rivera-
Del Valle et al. demonstrates that a novel hydroxamic acid
histone deacetylase inhibitor, PCI-24781, exerts cytotoxicity
and histone alterations in leukemia cells, via a mechanism
that is dependent on caspase-8 and Fas-associated death
domain. Another avenue for identifying novel therapeutic
targets for cancers is study of inﬂammation, since many
human malignancies have been strongly linked with chronic
inﬂammation. The review by C. Sobolewski et al. describes
the role of cyclooxygenase-2 in these diseases. This enzyme
is a member of a family, which catalyzes the rate-limiting
step of prostaglandin biosynthesis. Cyclooxygenase-2 is
upregulated during both inﬂammation and cancer, and has
been described to modulate cell proliferation and apoptosis
mainly in solid tumors and more recently in hematological
malignancies. Thus, the use of cyclooxygenase-2 inhibitors,
together with other therapeutic strategies, may further
improve the eﬃciency of anticancer treatments in the clinic.
In contrast to cancers, an important aim of research
into degenerative diseases is to discover novel ways to
inhibit cell death. One such disease is Parkinson’s disease,
where there are currently no therapies which halt the
degeneration of dopaminergic neurons. In the research
article by K. Mnich et al. the ability of the endoge-
nous cannabinoid, anandamide, to inhibit apoptotic cell
death by the Parkinson mimetic, 6-hydroxydopamine, was
shown. The protection provided by anandamide involved
activation of phosphatidylinositol 3-kinase and prevention
of 6-hydroxydopamine induced activation of c-Jun-NH2-
terminal kinase (JNK). These data add to the growing
body of literature concerning cannabinoids and Parkinson’s
disease. Certain other neurodegenerative diseases, termed
tauopathies, feature ﬁlamentous tau-positive protein inclu-
sions in neurons and glia, which are characterized by the
expression of stress response proteins, particularly heat
shock proteins (Hsps), in these inclusions. The article by L.
Schwarz et al. investigated the contribution of small Hsps,
Hsp27, and αB-crystallin, to neurodegenerative diseases by
analyzing the association of Hsp27 with pathological lesions
of tauopathies. Their results suggest distinct mechanisms for
Hsp27 action in glial and neuronal cells, with prominent
expression in unstressed astrocytes but with low expression
observed in neurons even after stress situations.
We hope that this special issue will alert researchers to
some new developments in the ﬁelds of cell stress and cell
death, particularly the interplay between prosurvival and
prodeath responses, and how our knowledge of these can
direct our eﬀorts in discovering new therapeutic strategies
for the treatment of cancers and degenerative diseases.
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